[HTML][HTML] Modified Gexiazhuyu decoction (膈下逐瘀汤加减方) alleviates chronic salpingitis via p38 signaling pathway

HU Xijiao, LI Shuoxi, Y Dongxia, GU Na… - Journal of Traditional …, 2022 - ncbi.nlm.nih.gov
OBJECTIVE To investigate pharmacodynamic effects of modified Gexiazhuyu decoction
(MGXZYD) and explore the underlying mechanism in the treatment of chronic salpingitis …

Modified Gexiazhuyu decoction alleviates chronic salpingitis p38 signaling pathway.

HU Xijiao, LI Shuoxi, Y Dongxia, GU Na… - Journal of Traditional …, 2022 - europepmc.org
Objective To investigate pharmacodynamic effects of modified Gexiazhuyu decoction
(MGXZYD) and explore the underlying mechanism in the treatment of chronic salpingitis …

Modified Gexiazhuyu decoction alleviates chronic salpingitis p38 signaling pathway

HU Xijiao, LI Shuoxi, Y Dongxia… - … medicine= Chung i …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective To investigate pharmacodynamic effects of modified Gexiazhuyu decoction
(MGXZYD) and explore the underlying mechanism in the treatment of chronic salpingitis …

Modified Gexiazhuyu decoction (膈下逐瘀汤加减方) alleviates chronic salpingitis via p38 signaling pathway.

HU Xijiao, LI Shuoxi, Y Dongxia… - Journal of …, 2022 - search.ebscohost.com
OBJECTIVE: To investigate pharmacodynamic effects of modified Gexiazhuyu decoction
(MGXZYD) and explore the underlying mechanism in the treatment of chronic salpingitis …